Search Results - Loman, Rhoda L

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157

    A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157 by Hahn, Noah M, Bivalacqua, Trinity J, Ross, Ashley E, Netto, George J, Baras, Alex, Park, Jong Chul, Chapman, Carolyn, Masterson, Timothy A, Koch, Michael O, Bihrle, Richard, Foster, Richard S, Gardner, Thomas A, Cheng, Liang, Jones, David R, McElyea, Kyle, Sandusky, George E, Breen, Timothy, Liu, Ziyue, Albany, Costantine, Moore, Marietta L, Loman, Rhoda L, Reed, Angela, Turner, Scott A, De Abreu, Francine B, Gallagher, Torrey, Tsongalis, Gregory J, Plimack, Elizabeth R, Greenberg, Richard E, Geynisman, Daniel M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy

    Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy by Thomas, Derek E., Kaimakliotis, Hristos Z., Rice, Kevin R., Pereira, Jose A., Johnston, Paul, Moore, Marietta L., Reed, Angela, Cregar, Dylan M., Franklin, Cindy, Loman, Rhoda L., Koch, Michael O., Bihrle, Richard, Foster, Richard S., Masterson, Timothy A., Gardner, Thomas A., Sundaram, Chandru P., Powell, Charles R., Beck, Stephen D.W., Grignon, David J., Cheng, Liang, Albany, Costantine, Hahn, Noah M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A PHASE II TRIAL OF DOVITINIB IN BCG-UNRESPONSIVE UROTHELIAL CARCINOMA WITH FGFR3 MUTATIONS OR OVER-EXPRESSION: HOOSIER CANCER RESEARCH NETWORK TRIAL HCRN 12-157

    A PHASE II TRIAL OF DOVITINIB IN BCG-UNRESPONSIVE UROTHELIAL CARCINOMA WITH FGFR3 MUTATIONS OR OVER-EXPRESSION: HOOSIER CANCER RESEARCH NETWORK TRIAL HCRN 12-157 by Hahn, Noah M., Bivalacqua, Trinity J., Ross, Ashley E., Netto, George J., Baras, Alex, Park, Jong Chul, Chapman, Carolyn, Masterson, Timothy A., Koch, Michael O., Bihrle, Richard, Foster, Richard S., Gardner, Thomas A., Cheng, Liang, Jones, David R., McElyea, Kyle, Sandusky, George E., Breen, Timothy, Liu, Ziyue, Albany, Costantine, Moore, Marietta L., Loman, Rhoda L., Reed, Angela, Turner, Scott A., De Abreu, Francine B., Gallagher, Torrey, Tsongalis, Gregory J., Plimack, Elizabeth R., Greenberg, Richard E., Geynisman, Daniel M.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Prognostic Impact of Carcinoma In Situ in Muscle Invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy

    Prognostic Impact of Carcinoma In Situ in Muscle Invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy by Thomas, Derek E, Kaimakliotis, Hristos Z, Rice, Kevin R, Pereira, Jose A, Johnston, Paul, Moore, Marietta L, Reed, Angela, Cregar, Dylan M, Franklin, Cindy, Loman, Rhoda L, Koch, Michael O, Bihrle, Richard, Foster, Richard S, Masterson, Timothy A, Gardner, Thomas A, Sundaram, Chandru P, Powell, Charles R, Beck, Stephen D.W, Grignon, David J, Cheng, Liang, Albany, Costantine, Hahn, Noah M

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: